NetworkNewsBreaks – PreveCeutical Medical Inc. (
Post# of 77
(Total Views: 180)
Posted On: 09/04/2018 5:47:53 PM
NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Develops Proprietary Cannabinoid Extraction Protocol
Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) today announced that it has successfully optimized its extraction protocol during its soluble gel (“Sol-gel”) drug delivery research and development program. The company augmented the circumstances for extracting cannabinoids from one of its cannabis strains and established a proprietary method for the accurate quantification of cannabinoids present in the extract. The accuracy and precision of the company’s extraction protocol was confirmed against eight commercial cannabinoid standards over a wide concentration range. PreveCeutical anticipates that the new protocol will accelerate the creation of a library of chemically fingerprinted cannabinoid extracts. Each unique extract will be optimized and incorporated into the company’s Sol-gel technology.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) today announced that it has successfully optimized its extraction protocol during its soluble gel (“Sol-gel”) drug delivery research and development program. The company augmented the circumstances for extracting cannabinoids from one of its cannabis strains and established a proprietary method for the accurate quantification of cannabinoids present in the extract. The accuracy and precision of the company’s extraction protocol was confirmed against eight commercial cannabinoid standards over a wide concentration range. PreveCeutical anticipates that the new protocol will accelerate the creation of a library of chemically fingerprinted cannabinoid extracts. Each unique extract will be optimized and incorporated into the company’s Sol-gel technology.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)PreveCeutical Medical Inc. (PRVCF) Stock Research Links
Scroll down for more posts ▼